Package 67877-585-30

Brand: eslicarbazepine acetate

Generic: eslicarbazepine acetate
NDC Package

Package Facts

Identity

Package NDC 67877-585-30
Digits Only 6787758530
Product NDC 67877-585
Product ID 67877-585_ca4bcb9f-157d-4d49-92f5-6b76745aabe1
Description

30 TABLET in 1 BOTTLE (67877-585-30)

Marketing

Marketing Status
Marketed Since 2025-05-06
Brand eslicarbazepine acetate
Generic eslicarbazepine acetate
Sample Package No

Linked Drug Pages (1)

Eslicarbazepine Acetate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ca4bcb9f-157d-4d49-92f5-6b76745aabe1", "openfda": {"upc": ["0367877588308", "0367877586304", "0367877585307"], "unii": ["BEA68ZVB2K"], "rxcui": ["1482507", "1482515", "1482521", "1482525"], "spl_set_id": ["28efe9d2-9d7b-4a7c-8458-098456d06604"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (67877-585-30)", "package_ndc": "67877-585-30", "marketing_start_date": "20250506"}], "brand_name": "Eslicarbazepine Acetate", "product_id": "67877-585_ca4bcb9f-157d-4d49-92f5-6b76745aabe1", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "67877-585", "generic_name": "Eslicarbazepine Acetate", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eslicarbazepine Acetate", "active_ingredients": [{"name": "ESLICARBAZEPINE ACETATE", "strength": "200 mg/1"}], "application_number": "ANDA211199", "marketing_category": "ANDA", "marketing_start_date": "20250506", "listing_expiration_date": "20261231"}